ANGELA ATTERBERRY: Open Payments
NPI 1902273907 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 15 payments from 8 companies in 2025. Trend: 2023 $320 · 2024 $670 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $130 |
| Lilly USA, LLC | 5 | $86 |
| PFIZER INC. | 4 | $72 |
| Amgen Inc. | 1 | $16 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Abbott Laboratories | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: WaveWriter Alpha Prime 16, PREVNAR 20, MOUNJARO, JARDIANCE, REPATHA, SHINGRIX, FREESTYLE LIBRE 3, VOQUEZNA.
Industry payments across OK — which companies pay providers there.
